Catalyst Wire Dossier Catalyst Wire Dossier

Rotavirus Vaccine (HRV) liquid

human rotavirus vaccine, live attenuated · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rotavirus Vaccine (HRV) liquid, covering 2019-10-31 to 2019-10-31. Get the full timeline:

Most recent: Clinical Trial Update: This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine [Phase 3]

See pricing